Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03401385
Title First-in-human Study of DS-1062a for Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Co., Ltd.
Indications

lung non-small cell carcinoma

Therapies

Datopotamab Deruxtecan

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.